Patent application number | Description | Published |
20090230020 | METHOD FOR SHIELDING RFID TAGGED DISCARDED ITEMS IN RETAIL, MANUFACTURING AND WHOLESALE INDUSTRIES - A method for shielding discarded or unwanted items provided with a Radio Frequency Identification (RFID) tag, comprises the following steps. First, a facility containing an inventory including a plurality of products each including a radio frequency identification (RFID) tag is provided. Then, the facility is provided with an RFID waste collection container defining a magnetic shielding enclosure for shielding and electromagnetically isolating the RFID tags when the products are disposed therein. Next, it is determined if one of the plurality of products is not wanted. Subsequently, the unwanted product is discarded by placing the unwanted product into the RFID waste collection container so that the RFID tag of the unwanted product does not interfere with ongoing activities in the facility by emitting errant signals. | 09-17-2009 |
20100212565 | METHOD FOR MANUFACTURING MULTI-PIECE ARTICLE USING RFID TAGS - A method for manufacturing a multi-piece article, such as a garment, comprises the following steps. First, at least two parts of the article are provided. Then, a radio frequency identification (RFID) tag is attached to each of the at least two parts of the article. Each of the RFID tags stores data including data identifying the part of the article associated with the RFID tag and manufacturing instructions identifying parts of the article to be connected. Next, the RFID tags including manufacturing instructions identifying matching parts of the article are scanned. Subsequently, the at least two parts of the article are connected together according to the manufacturing instructions obtained prior to the step of connecting the at least two parts so as to form at least a portion of the article. | 08-26-2010 |
Patent application number | Description | Published |
20120282298 | CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN - Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production. | 11-08-2012 |
20120288534 | Corticosteroids for the Treatment of Joint Pain - Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production. | 11-15-2012 |
20140242170 | Corticosteroids for the Treatment of Joint Pain - Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production. | 08-28-2014 |
20140356437 | Corticosteroids for the Treatment of Joint Pain - Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production. | 12-04-2014 |
20150025050 | Corticosteroids for the Treatment of Joint Pain - Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production. | 01-22-2015 |